News › Industry News, News

InMode Announces U.S. Patent for Fractional RF (Morpheus8)

November 11, 2020

InMode Ltd., a leading global provider of innovative medical technologies, has announced that the U.S. Patent and Trademark Office has granted to InMode Patent No. 10.799.285 covering its Morpheus8 full-body fractional radiofrequency (RF) technology.
Since its inception, InMode has invested significantly in R&D to independently develop state-of-the-art electro-surgical bi-polar radiofrequency devices, bringing to market breakthrough surgical procedures for the face, body and skin, as well as women’s health and wellness. Through its ongoing commitment to R&D, InMode has become a leader in disruptive technology and is credited with pioneering full body fractional RF technology through the commercialization of the Morpheus8 Subdermal Adipose Remodeling (SARD) device.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AmSpa CEO Reflects on the Sonya Dakar Case
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
    • GlossGenius Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • FDA Advisory Committee to Review Seven Peptides for Potential Use in Compounding
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
Advertisement